Expert Speaker Faculty

Meet the visionaries shaping the future of ALS & FTD care at the 5th ALS Drug Development Summit.

Pharma Powerhouses Driving Neuromuscular Innovation
Biotech Trailblazers Transforming ALS & FTD Therapeutics
Investors, Advocates & Strategic Voices
Academic Titans & Clinical Thought Leaders
CRO Innovators Accelerating CNS Research

Pharma Powerhouses Driving Neuromuscular Innovation

Yunfeng Huang, Principal Scientist, Biogen - Expert Speaker at the 5th ALS Drug Development Summit 2026

Yunfeng Huang

Principal Scientist
Biogen

Joyce Lo

Associate Director
Biogen
Joel Schwartz, Scientific Director, Bristol Myers Squibb - Expert Speaker at the 5th ALS Drug Development Summit 2026

Joel Schwartz

Director, Scientific Digital Biomarkers Neuroscience
Bristol Myers Squibb

Francisca Martinez Traub

Director
Eli Lilly

Yea Jin Kaeser-Woo

Senior Director
Eli Lilly

Enchi Liu

Vice President, Head of Experimental Medicine
Lundbeck
Arti Patel, Principal Scientist II, Novartis - Expert Speaker at the 5th ALS Drug Development Summit 2026 (1)

Arti Patel

Principal Scientist, Neuroscience & Program Lead
Novartis

Dominik Feuerbach

Associate Director, BioMedical Research, Neuroscience
Novartis

Derya Shimshek

Senior Principal Scientist, BioMedical Research, Neuroscience
Novartis

Mary Michael

Vice President, Patient Advocacy & Stakeholder Management
Otsuka

Alex Goddard

Director, Business Development, Investments
Otsuka
Ivan Nyarko-Danquah, Postdoctoral Fellow, Sanofi - Expert Speaker at the 5th ALS Drug Development Summit 2026

Ivan Nyarko-Danquah

Postdoctoral Fellow
Sanofi
Kelly Glajch, Scientific Director, Rare Neurology, Neuroscience Therapeutic Area Unit, Takeda - Expert Speaker at the 5th ALS Drug Development Summit 2026

Kelly Glajch

Scientific Director, Rare Neurology- Neuroscience Therapeutic Area Unit
Takeda
Makoto Tamura, Executive Director of NeuroDiscovery Lab, Mitsubishi Tanabe Pharma - Expert Speaker at the 5th ALS Drug Development Summit 2026

Makoto Tamura

Executive Director of NeuroDiscovery Lab
Tanabe Pharma America

Biotech Trailblazers Transforming ALS & FTD Therapeutics

Mansuo Lu Shannon, Chief Scientific Officer, Ask Bio - Expert Speaker at the 5th ALS Drug Development Summit 2026

Mansuo Lu Shannon

Chief Scientific Officer
Ask Bio
Christopher Shaw, Chief Scientific and Clinical Advisor, AviadoBio - Expert Speaker at the 5th ALS Drug Development Summit 2026

Christopher Shaw

Chief Scientific Officer & Clinical Advisor
AviadoBio
Javier San Martin, CMO, Athira Pharma - Expert Speaker at the 5th ALS Drug Development Summit 2026

Javier San Martin

Chief Medical Officer
LeonaBio

Sharon Tamir

Vice President of Clinical Development
Neurizon

Joseph Klim

Director of Neuroscience
NuCyRNA Therapeutics

Michal Geva

Senior Vice President, Head of Research
Prilenia
Sandy Hinckley, Vice President, Head of Discovery, Quralis - Expert Speaker at the 5th ALS Drug Development Summit 2026

Sandy Hinckley

Vice President, Head of Discovery
QurAlis
Sarah Knutson, Executive Director, Early Discovery, Rome Therapeutics - Expert Speaker at the 5th ALS Drug Development Summit 2026

Sarah Knutson

Executive Director, Early Discovery
ROME Therapeutics
Irina Antonijevic, Chief Medical Officer, Trace Neuroscience - Expert Speaker at the 5th ALS Drug Development Summit 2026

Irina Antonijevic

Chief Medical Officer
Trace Neuroscience
George Apostol, Senior Vice President, Clinical Development, uniQure - Expert Speaker at the 5th ALS Drug Development Summit 2026

George Apostol

Head of Clinical Development
uniQure

Investors, Advocates & Strategic Voices

Eloise Jarvis, Researcher, Beacon Intelligence - Expert Speaker at the 5th ALS Drug Development Summit 2026

Eloise Jarvis

Senior Researcher
Beacon Research Operations
Christian Rubio, Executive Director & Head of Development, EverythingALS - Expert Speaker at the 5th ALS Drug Development Summit 2026

Christian Rubio

Executive Director
Everything ALS

Kate Nycz

Vice President & ALS Advocate
HerALS Story
Hanxiong (Bear) Zhang, Associate, RA Capital Management - Expert Speaker at the 5th ALS Drug Development Summit 2026

Bear Zhang

Associate
RA Capital Management
Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation AbbVie- Expert Speaker at the 5th ALS Drug Development Summit 2026

Murali Gopalakrishnan

Vice President, Head of Search & Evaluation, Business Development - Innovative Medicine
Teva Pharmaceuticals

Academic Titans & Clinical Thought Leaders

Collin Hovinga, Vice President of Rare and Orphan Diseases, Critical Path Institute (C-Path) - Expert Speaker at the 5th ALS Drug Development Summit 2026

Collin Hovinga

Vice President of Rare & Orphan Diseases
Critical Path Institute
Phil Wong, Professor of Pathology, John Hopkins Medicine - Expert Speaker at the 5th ALS Drug Development Summit 2026

Philip C. Wong

Professor of Pathology
Johns Hopkins University
Ruth Chia, Staff Scientist, National Institutes of Health (NIH) - Expert Speaker at the 5th ALS Drug Development Summit 2026

Ruth Chia

Staff Scientist
National Institutes of Health (NIH)
John Replogle, Postdoctoral Fellow, The National Institutes of Health - Expert Speaker at the 5th ALS Drug Development Summit 2026

John Replogle

Postdoctoral Fellow
National Institutes of Health (NIH)

Hande Ozdinler

Associate Professor of Neuromuscular Disease in the Ken & Ruth Davee Department of Neurology
Northwestern University

Leonard van den Berg

Professor of Neurology, Neurologist & Chairman of TRICALS
UMC Utrecht

CRO Innovators Accelerating CNS Research

Matthew Mandeville, Senior Business Development Manager, BrainXell, - Expert Speaker at the 5th ALS Drug Development Summit 2026

Matt Mandeville

Senior Business Development Manager
BrainXell

Jennifer Prichard

Medical Director
Evestia Clinical

Shababa Masoud

Senior Scientist, Neuroscience
insitro

Marian Hruska-Plochan

Scientific Business Developer
MaxWell Biosystems

Urs Frey

Chief Executive Officer
MaxWell Biosystems

Tetsuya Tanaka

Vice President, Stem Cell Biology
Ricoh Biosciences

Feng Xuan

Founder & CEO
Spear Bio

Connor Maltby

Head of Translational Medicine
Ulysses Neuroscience
5th ALS Drug Development Event Image (3)
Explore the Agenda

Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 30+ expert speakers shaping the future of ALS & FTD

View Presentations & Speakers
5th ALS Drug Development Event Image (7)
Partner With Us

Showcase your solutions, connect with decision makers, and position your company as the go-to provider in neuromuscular and neurodegenerative research

Explore Sponsorship Options
5th ALS Drug Development Event Image (2)
Join Biopharma Experts

Network with pharma, biotech, diagnostics, academia, consortia, and patient voices driving real-world adoption

Register Now